Antheia, Inc.
Menlo Park, US · Founded 2013 · Delaware corporation · 8 known investors
Antheia uses engineered yeast and biosynthesis to produce key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines. Founded out of Stanford's Smolke Lab, the company aims to make pharmaceutical supply chains more resilient and reduce drug shortages.
Founders & leadership
Antheia, Inc. was founded in 2013 by Christina D. Smolke, Christina Smolke, and Kristy Hawkins.
CD
Christina D. SmolkeCo-founder
CS
Christina SmolkeCo-Founder & CEO
KH
Kristy HawkinsCo-Founder & CSO
ED
Eric d'EsparbesChief Financial Officer
ZM
Zack McGaheyChief Operating Officer
HP
Heidi PucelChief People Officer
Board
RS
Ram ShriramBoard director
CT
Catherine ThodeyBoard director
Investors · 8
America's Frontier FundArlington · $500K – $10M
Civilization Ventures Management, LlcTiburon · $1M – $10M
Lam Capital
Sherpalo VenturesMenlo Park
Global Health Investment CorporationreportedNew York
Also in the syndicate · 3
ATHOS KGleadEDBIGlobal Health Investment Corporation (GHIC)
Funding
SEC filings, press & company announcements$41.4M disclosed across 4 rounds · 2015–2026
- $24MSeries CJan 2026 · 3 sources
America's Frontier Fund (lead), ATHOS KG (lead), EDBI, Global Health Investment Corporation, Global Health Investment Corporation (GHIC)
Source ↗
▶$9.2MraisedSep 2018 · 5 investors · Other TechnologyRule 506(b)
▶$9.2MraisedSep 2018 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ram ShriramDirector
- Valerie MinassianExecutive Officer
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Offering amount
- $15.5M
- Amount sold
- $9.2M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedMay 2017 · 4 investors · Other TechnologyRule 506(b)
▶$6.2MraisedMay 2017 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Ram ShriramDirector
- Offering amount
- $25M
- Amount sold
- $6.2M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2MraisedMar 2015 · 10 investors · Other TechnologyRule 506(b)
▶$2MraisedMar 2015 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ram ShriramDirector
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Antheia, Inc. do?
- Antheia uses engineered yeast and biosynthesis to produce key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines. Founded out of Stanford's Smolke Lab, the company aims to make pharmaceutical supply chains more resilient and reduce drug shortages.
- Who founded Antheia, Inc.?
- Antheia, Inc. was founded by Christina D. Smolke, Christina Smolke, Kristy Hawkins in 2013.
- Who are Antheia, Inc.'s investors?
- Antheia, Inc.'s investors include America's Frontier Fund, Civilization Ventures Management, Llc, Lam Capital, Sherpalo Ventures, Global Health Investment Corporation.
- How much funding has Antheia, Inc. raised?
- Antheia, Inc. has disclosed $41.4M raised across 4 rounds.
- Where is Antheia, Inc. headquartered?
- Antheia, Inc. is headquartered in Menlo Park, US.